Company Profile
Globus Medical Stock Price, News & Analysis
- Ticker:
- GMED
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
81.08 USD (+0.67%)
Close
Last updated: August 6, 2026
10.6B USD
Market cap
Why the stock is moving
The latest monitored company update is “Globus Medical Reports Second Quarter 2026 Results.” The corresponding closing-price reaction is not yet available.
Company overview
Musculoskeletal Technology
Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation.
Implants and Enabling Technologies
The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction procedures.
Enabling Technologies
Globus provides navigation, imaging and robotic systems that support surgical planning and execution. These technologies create a broader procedural ecosystem around its implant portfolio.
Expanded Pain-Management Platform
Through Nevro, Globus also participates in spinal-cord stimulation and other neuromodulation therapies for chronic pain, broadening the company beyond its traditional spine and orthopedic markets.
Future catalysts
Globus Medical’s watchlist is robotics integration, spine-market share, and operating synergy realization. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name ahead of the following catalyst.
Recent news
- 01
Globus Medical Reports Second Quarter 2026 Results
Source: Globus Medical
- 02
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
Source: Globus Medical
- 03
Globus Medical Reports First Quarter 2026 Results
Source: Globus Medical
- 04
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Source: Globus Medical
- 05
Globus Medical Announces Board Departure
Source: Globus Medical
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Globus Medical (GMED)?
Globus Medical (GMED) most recently closed at 81.08 USD, a +0.67% move versus the previous session.
What is the market cap of Globus Medical (GMED)?
Globus Medical currently has a market capitalization of 10.6B USD on BioPharmSignal.
What does Globus Medical do?
Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation. Implants and Enabling Technologies The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction...
On which exchange is GMED stock listed?
Globus Medical (GMED) is associated with NYSE, United States, Biopharma.
What is Musculoskeletal?
Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care.
Which conditions is Globus Medical targeting with Musculoskeletal?
Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation. Implants and Enabling Technologies The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction...
How does Globus Medical describe recent progress with Musculoskeletal?
Globus Medical’s watchlist is robotics integration, spine-market share, and operating synergy realization. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name ahead of the following catalyst.
What is Technology?
Musculoskeletal Technology Globus Medical develops products and technologies for musculoskeletal care.